{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:17:09Z","timestamp":1769606229321,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jiac.2022.06.006","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T02:26:12Z","timestamp":1655346372000},"page":"1364-1369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mortality changes for patients with pneumococcal pneumonia from 2012 to 2017 in Japan"],"prefix":"10.1016","volume":"28","author":[{"given":"Shingo","family":"Noguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2955-4432","authenticated-orcid":false,"given":"Kazuhiro","family":"Yatera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.06.006_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","article-title":"Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study","volume":"17","author":"Suzuki","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2022.06.006_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2022.06.006_bib3","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1183\/09031936.00183614","article-title":"Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia","volume":"45","author":"Rodrigo","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2022.06.006_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200504","article-title":"Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia","volume":"13","author":"Cilloniz","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2022.06.006_bib5","article-title":"A retrospective study of the clinical burden of hospitalized all-cause and pneumococcal pneumonia in Canada","volume":"2016","author":"McNeil","year":"2016","journal-title":"Can Respir J J Can Thorac Soc"},{"key":"10.1016\/j.jiac.2022.06.006_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209428","article-title":"Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly","volume":"14","author":"Kislaya","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2022.06.006_bib7","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1016\/j.vaccine.2017.06.049","article-title":"Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands","volume":"35","author":"Vestjens","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jiac.2022.06.006_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1469-0691.2012.03895.x","article-title":"Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia","volume":"19","author":"Burgos","year":"2013","journal-title":"Clinical microbiology and infection"},{"key":"10.1016\/j.jiac.2022.06.006_bib9","article-title":"Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015","volume":"7","author":"LeBlanc","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jiac.2022.06.006_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.vaccine.2019.10.031","article-title":"Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): a nationwide retrospective database analysis","volume":"38","author":"Gajewska","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2022.06.006_bib11","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1016\/j.vaccine.2019.05.003","article-title":"Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: a study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)","volume":"37","author":"LeBlanc","year":"2019","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.jiac.2022.06.006_bib12","first-page":"35","article-title":"Development of case mix based evaluation system in Japan","author":"Matsuda","year":"2016","journal-title":"Jpn Hosp"},{"key":"10.1016\/j.jiac.2022.06.006_bib13","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1002\/hpm.1051","article-title":"Contribution of case-mix classification to profiling hospital characteristics and productivity","volume":"26","author":"Kuwabara","year":"2011","journal-title":"Int J Health Plann Manag"},{"key":"10.1016\/j.jiac.2022.06.006_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1017\/S0950268807008564","article-title":"ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged > or = 65 years","volume":"136","author":"Skull","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jiac.2022.06.006_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1253\/circj.66.987","article-title":"New criteria for 'obesity disease' in Japan","volume":"66","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.jiac.2022.06.006_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijid.2020.10.019","article-title":"Factors associated with mortality among patients with necrotizing soft tissue infections: an analysis of 4597 cases using the Diagnosis Procedure Combination Database","volume":"102","author":"Suzuki","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2022.06.006_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1440-1843.2008.01329.x","article-title":"Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia","volume":"13","author":"Shindo","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2022.06.006_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jiac.2016.07.008","article-title":"Risk factors for the severity and mortality of pneumococcal pneumonia: importance of premorbid patients' performance status","volume":"22","author":"Ishiguro","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.06.006_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1378\/chest.13-2853","article-title":"Tobacco smoking increases the risk for death from pneumococcal pneumonia","volume":"146","author":"Bello","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2022.06.006_bib20","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/cc11471","article-title":"Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study","volume":"16","author":"Mongardon","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2022.06.006_bib21","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","article-title":"Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia","volume":"37","author":"Isturiz","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2022.06.006_bib22","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6085","article-title":"The impact of pneumococcal vaccination on pneumonia mortality among the elderly in Japan: a difference-in-difference study","volume":"6","author":"Jung","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.jiac.2022.06.006_bib23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.06.006_bib24","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.vaccine.2019.11.012","article-title":"Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: the EPIVAC cohort study, 2015-2016","volume":"38","author":"Vila-Corcoles","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2022.06.006_bib25","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.vaccine.2019.04.017","article-title":"Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: a case-control study","volume":"37","author":"Kim","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2022.06.006_bib26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cmi.2017.08.010","article-title":"Impact of pneumococcal polysaccharide vaccine on incidence and mortality after pneumonia in adults aged >\/=60 years-a population-based retrospective cohort study","volume":"24","author":"Kolditz","year":"2018","journal-title":"Clinical microbiology and infection"},{"key":"10.1016\/j.jiac.2022.06.006_bib27","unstructured":"http:\/\/www\/mhlw.go.jp\/topics\/bcg\/other\/5.html (accessed 17 March 2022)."},{"key":"10.1016\/j.jiac.2022.06.006_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jinf.2012.08.011","article-title":"Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia","volume":"66","author":"Kang","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2022.06.006_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/joim.12984","article-title":"Higher frequency of hospitalization but lower relative mortality for pandemic influenza in people with type 2 diabetes","volume":"287","author":"Ruiz","year":"2020","journal-title":"J Intern Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:34Z","timestamp":1761159874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1341321X22001817"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.06.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality changes for patients with pneumococcal pneumonia from 2012 to 2017 in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}